Left ventricular lead placement in the latest activated region guided by coronary venous electroanatomic mapping

Europace

Volumn 17, Issue 1, 2014, Pages 84-93

  Rad, Masih Mafi ^a   Blaauw, Yuri ^a   Dinh, Trang ^a   Pison, Laurent ^a   Crijns, Harry J ^a   Prinzen, Frits W ^b   Vernooy, Kevin ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cardiac resynchronization therapy; Electroanatomic mapping; Feasibility; Left ventricular electrical activation; Left ventricular lead placement

Indexed keywords

AGED; ANATOMIC LANDMARK; ARTICLE; CARDIAC MAPPING SYSTEM; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR PROCEDURE; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY VEIN; CORONARY VEIN STENOSIS; CORONARY VENOUS ELECTROANATOMIC MAPPING; ELECTRODE IMPLANTATION; FEASIBILITY STUDY; FEMALE; GUIDE WIRE; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT VENTRICULAR LEAD PLACEMENT; MALE; NERVE STIMULATION; PHRENIC NERVE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QRS COMPLEX; STENOSIS; BUNDLE-BRANCH BLOCK; CORONARY BLOOD VESSEL; ELECTROCARDIOGRAPHY; ELECTRODE IMPLANT; HEART CATHETERIZATION; HEART VENTRICLE; PROCEDURES; PROSTHESIS IMPLANTATION; SURGERY; TREATMENT OUTCOME;

AGED; BODY SURFACE POTENTIAL MAPPING; BUNDLE-BRANCH BLOCK; CARDIAC CATHETERIZATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CORONARY VESSELS; ELECTRODES, IMPLANTED; FEMALE; HEART VENTRICLES; HUMANS; MALE; PROSTHESIS IMPLANTATION; TREATMENT OUTCOME;

EID: 84922451566     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu221     Document Type: Article

References (42)

1. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure.NEngl J Med 2005;352:1539-49
2. Linde C, AbrahamWT, Gold MR, St John Sutton M, Ghio S, Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834-43
3. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38
4. Daubert JC, Saxon L, Adamson PB, Auricchio A, Berger RD, Beshai JF, et al. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace 2012;14:1236-86
5. Gold MR, Birgersdotter-Green U, Singh JP, Ellenbogen KA, Yu Y, Meyer TE, et al. The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy. Eur Heart J 2011;32:2516-24
6. Zanon F, Baracca E, Pastore G, FraccaroC, Roncon L, Aggio S, et al. Determination of the longest intra-patient left ventricular electrical delay may predict acute hemodynamic improvement in cardiac resynchronization therapy patients. Circ Arrhythm Electrophysiol 2014;7:377-83
7. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 2013;15:1070-118
8. Fung JW, Yu CM, Yip G, Zhang Y, Chan H, Kum CC, et al. Variable left ventricular activation pattern in patients with heart failure and left bundle branch block. Heart 2004;90:17-9
9. Auricchio A, Fantoni C, Regoli F, Carbucicchio C, Goette A, Geller C, et al. Characterization of left ventricular activation in patients with heart failure and left bundlebranch block. Circulation 2004;109:1133-9
10. Rodriguez LM, Timmermans C, Nabar A, Beatty G,Wellens HJ. Variable patterns of septal activation in patients with left bundle branch block and heart failure. J Cardiovasc Electrophysiol 2003;14:135-41
11. Ryu K, D'Avila A, Heist EK, Rosenberg SP, Chou J, Yang M, et al. Simultaneous electrical and mechanical mapping using 3D cardiac mapping system: novel approach for optimal cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2010;21: 219-22
12. Del Greco M, Marini M, Bonmassari R. Implantation of a biventricular implantable cardioverter-defibrillator guided by an electroanatomic mapping system. Europace 2012;14:107-11
13. Cosio FG. The electrocardiogram. In Camm AJ (ed) The ESC Textbook of Cardiovascular Medicine 2009. 2nd edn. UK: Oxford University Press; 2009
14. De Cock CC, Res JC, Hendriks ML, Allaart CP. Usefulness of a pacing guidewire to facilitate left ventricular lead implantation in cardiac resynchronization therapy. Pacing Clin Electrophysiol 2009;32:446-9
15. Cerqueira MD,Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, LaskeyWK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42
16. Ypenburg C, van Bommel RJ, Delgado V, Mollema SA, Bleeker GB, Boersma E, et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol 2008;52:1402-9
17. AnsaloneG, Giannantoni P, Ricci R, Trambaiolo P, Fedele F, Santini M. Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing. J Am Coll Cardiol 2002;39:489-99
18. Becker M, Altiok E, Ocklenburg C, Krings R, Adams D, Lysansky M, et al. Analysis of LV lead position in cardiac resynchronization therapy using different imaging modalities. JACC Cardiovasc Imaging 2010;3:472-81
19. Becker M, Franke A, Breithardt OA, Ocklenburg C, Kaminski T, Kramann R, et al. Impact of left ventricular lead position on the efficacy of cardiac resynchronisation therapy: a two-dimensional strain echocardiography study. Heart 2007;93: 1197-203
20. Becker M, Hoffmann R, Schmitz F, Hundemer A, Kuhl H, Schauerte P, et al. Relation of optimal lead positioning as defined by three-dimensional echocardiography to longterm benefit of cardiac resynchronization. Am J Cardiol 2007;100:1671-6
21. Becker M, Kramann R, Franke A, Breithardt OA, Heussen N, Knackstedt C, et al. Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography. Eur Heart J 2007;28:1211-20
22. Bakos Z, Ostenfeld E, Markstad H, Werther-Evaldsson A, Roijer A, Arheden H, et al. A comparison between radial strain evaluation by speckle-tracking echocardiography and cardiac magnetic resonance imaging, for assessment of suitable segments for left ventricular lead placement in cardiac resynchronization therapy. Europace 2014;16:1779-86
23. Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O'Halloran D, Elsik M, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol 2012;59: 1509-18
24. Saba S, Marek J, Schwartzman D, Jain S, Adelstein E, White P, et al. Echocardiographyguided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial. Circ Heart Fail 2013;6:427-34
25. Singh JP, Fan D, Heist EK, Alabiad CR, Taub C, Reddy V, et al. Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy. Heart Rhythm 2006;3:1285-92
26. van Gelder BM, Meijer A, Bracke FA. Timing of the left ventricular electrogram and acute hemodynamic changes during implant of cardiac resynchronization therapy devices. Pacing Clin Electrophysiol 2009;32 (Suppl 1):S94-7
27. Singh JP, Klein HU, Huang DT, Reek S, Kuniss M, Quesada A, et al. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation 2011;123: 1159-66
28. Gold MR, Auricchio A,Hummel JD, Giudici MC,Ding J, TockmanB, et al. Comparison of stimulation sites within left ventricular veins on the acute hemodynamic effects of cardiac resynchronization therapy. Heart Rhythm 2005;2:376-81
29. Foley PW, Chalil S, Ratib K, Smith R, Prinzen F, Auricchio A, et al. Fluoroscopic left ventricular lead position and the long-termclinical outcome of cardiac resynchronization therapy. Pacing Clin Electrophysiol 2011;34:785-97
30. Jastrzebski M, Wilinski J, Fijorek K, Sondej T, Czarnecka D. Mortality and morbidity in cardiac resynchronization patients: impact of lead position, paced left ventricular QRS morphology and other characteristics on long-term outcome. Europace 2013;15:258-65
31. Saxon LA, Olshansky B, Volosin K, Steinberg JS, Lee BK, Tomassoni G, et al. Influence of left ventricular lead location on outcomes in theCOMPANIONstudy. J Cardiovasc Electrophysiol 2009;20:764-8
32. Bleeker GB, Schalij MJ, Van DerWall EE, Bax JJ. Postero-lateral scar tissue resulting in non-response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006; 17:899-901
33. Hummel JP, Lindner JR, Belcik JT, Ferguson JD, Mangrum JM, Bergin JD, et al. Extent of myocardial viability predicts response to biventricular pacing in ischemic cardiomyopathy. Heart Rhythm 2005;2:1211-7
34. Ypenburg C, Roes SD, Bleeker GB, Kaandorp TA, De Roos A, Schalij MJ, et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol 2007;99:657-60
35. Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P, et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J 2007;28:33-41
36. Chalil S, Stegemann B, Muhyaldeen SA, Khadjooi K, Foley PW, Smith RE, et al. Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy. Pacing Clin Electrophysiol 2007;30: 1201-9
37. Fujiwara R, Yoshida A, Fukuzawa K, Takei A, Kiuchi K, Itoh M, et al. Discrepancy between electrical and mechanical dyssynchrony in patients with heart failure and an electrical disturbance. Pacing Clin Electrophysiol 2013;37:576-84
38. Boogers MJ, Chen J, van Bommel RJ, Borleffs CJ, Dibbets-Schneider P, van Der Hiel B, et al. Optimal left ventricular lead position assessed with phase analysis on gated myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging 2011;38: 230-8
39. Kandala J, Upadhyay GA, Altman RK, Parks KA, Orencole M, Mela T, et al. QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy. Eur Heart J 2013;34:2252-62
40. Gurevitz O, Nof E, Carasso S, Luria D, Bar-Lev D, Tanami N, et al. Programmable multiple pacing configurations help to overcome high left ventricular pacing thresholds and avoid phrenic nerve stimulation. Pacing Clin Electrophysiol 2005; 28:1255-9
41. Biffi M, Moschini C, Bertini M, Saporito D, Ziacchi M, Diemberger I, et al. Phrenic stimulation: a challenge for cardiac resynchronization therapy. Circ Arrhythm Electrophysiol 2009;2:402-10
42. Seifert M, Schau T, Moeller V, Neuss M, Meyhoefer J, Butter C. Influence of pacing configurations, body mass index, and position of coronary sinus lead on frequency of phrenic nerve stimulation and pacing thresholds under cardiac resynchronization therapy. Europace 2010;12:961-7